A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

Clinical trial NCT04217278 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04217278
Sponsor: University of Birmingham
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia High-risk Myelodysplastic Syndrome

Start date: 2020-01-27
Primary completion: 2026-05-01
Enrollment: 333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.